Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Nov 27, 2024; 16(11): 3520-3530
Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3520
Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3520
Analysis of therapeutic effect of cell reduction combined with intraperitoneal thermoperfusion chemotherapy in treatment of peritoneal pseudomyxoma
Wei-Wei Li, Xiu-Mei Ru, Hong-Yan Xuan, Jun Lu, Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, Jiangsu Province, China
Qi Fan, Jing-Jing Zhang, Department of Anus and Intestine Surgery, Xiangya Hospital of Central South University, Changsha 410008, Hunan Province, China
Author contributions: Li WW wrote the manuscript; Ru XM, Xuan HY, Fan Q and Zhang JJ collected the data; Lu J guided the study. All authors reviewed, edited, and approved the final manuscript and revised it critically for important intellectual content, gave final approval of the version to be published, and agreed to be accountable for all aspects of the work.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Second Affiliated Hospital of Soochow University.
Informed consent statement: This study has obtained informed consent and signed treatment consent from patients and their families.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: Statistical analysis plan, informed consent form, and clinical study report will also be shared if requested. Emails could be sent to the address mrfanqi2020@163.com to obtain the shared data.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jun Lu, Doctor, Department of Endocrinology, The Second Affiliated Hospital of Soochow University, No. 1055 Sanxiang Road, Suzhou 215004, Jiangsu Province, China. lujun.198404@163.com
Received: February 21, 2024
Revised: September 6, 2024
Accepted: September 12, 2024
Published online: November 27, 2024
Processing time: 252 Days and 8.8 Hours
Revised: September 6, 2024
Accepted: September 12, 2024
Published online: November 27, 2024
Processing time: 252 Days and 8.8 Hours
Core Tip
Core Tip: This study analyzed the efficacy of cell reduction combined with intraperitoneal thermoperfusion chemotherapy in the treatment of peritoneal pseudomyxoma (PMP). We will observe and study this treatment method, compare its efficacy with traditional chemotherapy methods, and explore the possible mechanism of action and adverse reactions of this method. This study will provide new ideas and methods for the treatment of PMP.